Jacobio Pharmaceuticals Group Co., Ltd.

HK$4.66As of Sun 8 Nov 2026, 12:00 UTC
HKEX:1167Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 6Y CAGR (17.29%)
Div yield —
ROE 46.30%
Biotechnology
Beta (5Y) 0.34
PE TTM 6.086
TSR TTM (36.86%)
Mkt cap HK$3.645B
ROIC 25.09%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$5.63
20.73%
(29.40%)
Hold 11|6|1|1|9
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.06
0.07
0.07
0.07
0.87%
9.72%
7.48%
8.86%
Revenue¥M
247.6
250.0
252.6
262.4
4.06%
7.83%
6.41%
4.64%
Peers (US$465.0M)
Cap (US$)
PE
465.7M
—
Capital
TTM
5Y
10Y
Leveragex
0.573
0.017
0.016
EBIT/Intx
1.698
0.717
0.713
Own earn%
(49.92)
1.84
(9.65)
Sh yield%
37.12
33.40
33.23
Owners
Insiders/Inst%
5.31
69.54
Short interest%
2.26
SBC / revenue%
3.04
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
22–26
$1 testx
0.0
Incr. ROIC%
77